Multi-State Life Sciences Association Congressional Briefing: Federal Investment in Biomedical Innovation – NIH and FDA
Washington D.C. | Rayburn 2043
Federal Investment in Biomedical Innovation: NIH and FDA
in cooperation with
Hon. Leonard Lance (R-NJ) and Hon. Scott Peters (D-CA); Co-Chairs, Congressional Life Science Caucus
June 5, 2017 | 12:00 -1:15 PM
Please join us for a discussion about the importance of funding for the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The NIH funds basic research and supports the work of research institutions and small companies across the country, while the FDA ensures the timely review of safe and effective products. Together, they make today’s medical discoveries and scientific innovations possible.
Participants will learn about how the agencies fuel biomedical innovation, work with private industry and academia to advance global human health, and give hope to patients in need. They will also hear about the need for continued funding and the impact of budget cuts on health outcomes, the economy, and global leadership in medical research.
Lunch will be served. Speakers will be available for individual Q&A after the program.
This event will be held in strict accordance with House and Senate Ethics rules. Food and refreshments of a nominal value will be provided as allowed by House Rule 25, clause 5(a)(4)(A) and Senate Rule 35.1(d)(1).
Please RSVP directly to Adam Lotspike, CLSA’s Associate Director of Federal Government Relations at email@example.com.